April 2025, From the Field
Often we find opportunities to invest in companies that are facing challenges—and occasionally controversies—that deter other investors, resulting in attractive valuation entry points. From there, we deploy our analysis, patience, pattern recognition, and partnership as part of our “fixable and lovable” strategy.
The fixable part of this strategy is to identify stocks with self‑improvement potential that is not dependent on market conditions (although we do, of course, aim to use macro weakness to our advantage). The lovable test seeks to answer the question: Could this stock go from being disregarded to becoming a core compounding holding with a premium valuation?
This approach accomplishes two things: First, it amplifies the stock upside potential beyond the repair in earnings per share and free cash flow (FCF). Second, it helps reduce the likelihood of value traps that are natural hazards of value investing. We often find the confluence of fixable and lovable in situations where there also is cyclical weakness but there also is potential for secular strength that the market cannot yet appreciate because of negative newsflow.
Recently, an opportunity arose to work closely with a company as part of our fixable and lovable strategy. The company in question, which we will refer to as Company A, has a very long track record of innovation in the materials science field that has led to numerous world‑changing inventions spanning across data communications, consumer electronics, and even pharmaceutical applications. As part of our lovable test, we often ask: Would the world care if this company didn’t exist? After following Company A for many years, we believe the answer is a resounding “yes.”
"…we often ask: Would the world care if this company didn’t exist?"
Vincent DeAugustino, Portfolio Manager, Mid‑Cap Value
Source: T. Rowe Price.
Several years ago, the opportunity to invest in Company A arose after its main businesses experienced end‑market weakness simultaneously despite a history of diversified performance. In addition to these challenges, Company A’s penchant for innovation and recent capacity additions gave investors pause over future capital allocation during a period of stress that could pressure FCF. Further, significant foreign exchange pressures were building, creating financial statement restatement risk. However, our analysis indicated that these problems could be fixed.
Following analyst Anna Nussbaum’s recommendation to incept positions, Portfolio Manager Vincent DeAugustino followed a familiar path of engagement with Anna and Company A. This led to multiple road trips over a three year period to Company A’s headquarters, research center, and various factories—many of which are located in small communities.
This combination of financial analysis and deep field work gave us a far greater appreciation for the investments Company A had undertaken and the new applications it was seeking to address, particularly in the data communications space. We also detected an early change in Company A’s capital allocation trajectory. If Company A’s end markets could recover at the same time new products were launched without the need for additional capital expenditures, we believed it should see a powerful inflection in FCF and return on invested capital (ROIC)—which were not anticipated by the market given the present challenges.
We partnered with our Investments Data Insights (IDI) team to quantify the historical stock outcomes when companies experienced similar FCF and ROIC improvement trajectories. While our analyses are normally used for the sole purpose of informing our own investment decisions, we will, when appropriate, share our insights with portfolio companies. In this case, our longstanding relationship with Company A led to an invitation to present to the CFO and others from the financial team after our initial discussions.
We partnered further to augment the IDI data with investment case studies where we had observed similar patterns in the past. This presentation allowed Anna and Vincent to share how Company A fit into the analysis and where there were opportunities to improve in capital allocation and address investor concerns—namely, that Company A’s innovation could command pricing power, that more focus was needed on project selection to deliver incremental FCF when revenues normalized, and that foreign exchange risk was a barrier for many investors.
That presentation and our subsequent discussions with the CEO boosted our confidence in our investment thesis, which supported increasing our investment in Company A.
Over the past year, Company A’s end markets have begun to recover and contract renegotiations have resolved foreign exchange restatement risk, although ongoing wider market issues continue to pose challenges. While these cyclical improvements are positives for the stock, we’re more deeply encouraged by other developments. Company A is seeing success with new product launches and has commenced a formal project outlining its expectation for strong revenue growth to drive high incremental margins without a ramp in capital expenditures.
Company A has also communicated a commitment to, and has begun returning excess capital to shareholders given this significant ramp in FCF. At the end of January Company A’s stock had gained almost 70% from the year-ago period before falling back during the ongoing market correction that started earlier this year. On 24 April, the stock was up 36% relative to 24 April 2024.
It is important to stress that we regard our work with Company A as a collaboration—this was not an activist situation in which we were seeking to pressure the company into taking a particular course of action. Partnership between Anna and Vincent, including both financial analysis and time in the field, led to a deeper relationship with Company A within the balance of our responsibilities to our clients.
"…we lean in to challenges among companies that we think can reemerge stronger…."
Anna Nussbaum, Investment Analyst
To conclude, through our journeys to identify fixable and lovable stocks, we lean in to challenges among companies that we think can reemerge stronger and, in the process, command improved valuations. When analysts and portfolio managers join forces, we can build relationships with companies along this journey that give us the confidence to build larger positions to benefit our clients.
The company example provided is for illustrative purposes only and does not represent other securities purchased, sold, or recommended for advisory clients at the firm. No assumptions should be made that investments in the securities identified and discussed were or will be profitable.
Important Information
This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a guarantee or a reliable indicator of future results. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.
The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.
Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass.
The views contained herein are as of April 2025 and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.
The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. It is not intended for distribution to retail investors in any jurisdiction.
Australia—Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. For Wholesale Clients only.
Canada—Issued in Canada by T. Rowe Price (Canada), Inc. T. Rowe Price (Canada), Inc.’s investment management services are only available to non‑individual Accredited Investors and non-individual Permitted Clients as defined under National Instrument 45-106 and National Instrument 31-103, respectively. T. Rowe Price (Canada), Inc. enters into written delegation agreements with affiliates to provide investment management services.
EEA—Unless indicated otherwise this material is issued and approved by T. Rowe Price (Luxembourg) Management S.à r.l. 35 Boulevard du Prince Henri L-1724 Luxembourg which is authorised and regulated by the Luxembourg Commission de Surveillance du Secteur Financier. For Professional Clients only.
New Zealand— Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. No Interests are offered to the public. Accordingly, the Interests may not, directly or indirectly, be offered, sold or delivered in New Zealand, nor may any offering document or advertisement in relation to any offer of the Interests be distributed in New Zealand, other than in circumstances where there is no contravention of the Financial Markets Conduct Act 2013.
Switzerland—Issued in Switzerland by T. Rowe Price (Switzerland) GmbH, Talstrasse 65, 6th Floor, 8001 Zurich, Switzerland. For Qualified Investors only.
UK—This material is issued and approved by T. Rowe Price International Ltd, Warwick Court, 5 Paternoster Square, London EC4M 7DX which is authorised and regulated by the UK Financial Conduct Authority. For Professional Clients only.
USA—Issued in the USA by T. Rowe Price Associates, Inc., 1307 Point Street, Baltimore, MD 21231, which is regulated by the U.S. Securities and Exchange Commission. For Institutional Investors only.
© 2025 T. Rowe Price. All Rights Reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, the Bighorn Sheep design, and related indicators (troweprice.com/en/intellectual-property) are trademarks of T. Rowe Price Group, Inc. All other trademarks are the property of their respective owners.